You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

OMNIPAQUE 180 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Omnipaque 180 patents expire, and when can generic versions of Omnipaque 180 launch?

Omnipaque 180 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in OMNIPAQUE 180 is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OMNIPAQUE 180?
  • What are the global sales for OMNIPAQUE 180?
  • What is Average Wholesale Price for OMNIPAQUE 180?
Drug patent expirations by year for OMNIPAQUE 180
Recent Clinical Trials for OMNIPAQUE 180

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fédération des médecins résidents du QuébecPhase 4
Centre for Interdisciplinary Research in Rehabilitation of Greater MontrealPhase 4
Claire BourgeoisPhase 4

See all OMNIPAQUE 180 clinical trials

Pharmacology for OMNIPAQUE 180

US Patents and Regulatory Information for OMNIPAQUE 180

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare OMNIPAQUE 180 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-001 Dec 26, 1985 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for OMNIPAQUE 180

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare OMNIPAQUE 180 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-001 Dec 26, 1985 4,021,481 ⤷  Subscribe
Ge Healthcare OMNIPAQUE 180 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-001 Dec 26, 1985 4,396,597 ⤷  Subscribe
Ge Healthcare OMNIPAQUE 180 iohexol SOLUTION;INJECTION, ORAL, RECTAL 018956-001 Dec 26, 1985 4,250,113 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for OMNIPAQUE 180

See the table below for patents covering OMNIPAQUE 180 around the world.

Country Patent Number Title Estimated Expiration
Sweden 445971 FORFARANDE FOR FRAMSTELLNING AV INJICERBART RONTGENKONTRASTMEDEL SAMT EN LOSNING AV NEMNDA MEDEL ⤷  Subscribe
Ireland 48437 A PROCESS FOR THE PREPARATION OF A STERILE INJECTABLE PHYSIOLOGICALLY ACCEPTABLE SOLUTION OF AN X-RAY CONTRAST AGENT AND SOLUTIONS OF THE X-RAY CONTRAST AGENT AND A BUFFER ⤷  Subscribe
Finland 792101 ⤷  Subscribe
France 2053037 ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.